Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen's Neulasta June 11, 2017 Biogen Shows Off More Positive Alzheimer???s Trial Data August 27, 2017 Novartis Buys Access to Spark's Landmark Gene Therapy Drug With $170M Deal January 24, 2018